After a long time languishing in the margins, paediatric HIV has gained a little more attention over the past few years, including a dedicated annual meeting organised by Virology Education, scheduled to precede the IAS one, and now at number four.
Although investigators have the opportunity to submit abstracts to both conferences -- so there is some duplication -- the workshop provides a very focused update on an area of research that is often harder to find at the big meeting, where basic and clinical science gets eclipsed by rhetoric (particularly where babies and children are concerned).
In addition, the Drugs for Neglected Diseases initiative (DNDi), alongside the International AIDS Society-Industry Liaison Forum (IAS-ILF) organised a symposium entitled Catching Children Before They Fall: Addressing Urgent Needs in Developing Drugs for Young Children Living with HIV. This satellite looked at the development of drugs and formulations for infants and young children in resource-limited settings, reflecting DNDi's recent non-profit R&D work to do exactly that.
Paediatric reports in this issue of HTB include:
Links to other websites are current at date of posting but not maintained.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|